Dianthus Therapeutics (DNTH) Other Non Operating Income (2022 - 2025)
Historic Other Non Operating Income for Dianthus Therapeutics (DNTH) over the last 4 years, with Q3 2025 value amounting to -$360000.0.
- Dianthus Therapeutics' Other Non Operating Income fell 65000.0% to -$360000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$947000.0, marking a year-over-year decrease of 24562.04%. This contributed to the annual value of -$554000.0 for FY2024, which is 55176.47% down from last year.
- Per Dianthus Therapeutics' latest filing, its Other Non Operating Income stood at -$360000.0 for Q3 2025, which was down 65000.0% from -$107000.0 recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Other Non Operating Income ranged from a high of $56000.0 in Q3 2022 and a low of -$382000.0 during Q4 2024
- In the last 4 years, Dianthus Therapeutics' Other Non Operating Income had a median value of -$48000.0 in 2024 and averaged -$95230.8.
- In the last 5 years, Dianthus Therapeutics' Other Non Operating Income plummeted by 116666.67% in 2024 and then skyrocketed by 1403.51% in 2025.
- Dianthus Therapeutics' Other Non Operating Income (Quarter) stood at -$20000.0 in 2022, then tumbled by 60.0% to -$32000.0 in 2023, then plummeted by 1093.75% to -$382000.0 in 2024, then rose by 5.76% to -$360000.0 in 2025.
- Its last three reported values are -$360000.0 in Q3 2025, -$107000.0 for Q2 2025, and -$98000.0 during Q1 2025.